Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-12-02T21:17:30.412Z Has data issue: false hasContentIssue false

Control of Healthcare-Associated Staphylococcus aureus Survey of Practices in North Carolina Hospitals

Published online by Cambridge University Press:  02 January 2015

David J. Weber*
Affiliation:
Division of Infectious Diseases, University of North Carolina, Chapel Hill
Karen K. Hoffmann
Affiliation:
Division of Infectious Diseases, University of North Carolina, Chapel Hill
William A. Rutala
Affiliation:
Division of Infectious Diseases, University of North Carolina, Chapel Hill
Deborah G. Pyatt
Affiliation:
Division of Infectious Diseases, University of North Carolina, Chapel Hill
*
2163 Bioinfor-matics, CB 7030, Chapel Hill, NC 27599-7030 ([email protected])

Abstract

Although patients colonized or infected with methicillin-resistant Staphylococcus aureus have been placed on contact isolation for many years, more recent guidelines recommend enhanced control measures, such as routine active surveillance. We report here the results of a survey of 70 hospitals in North Carolina with regard to current management issues surrounding methicillin-resistant S. aureus.

Type
Concise Communication
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hidron, AI, Edwards, JR, Patel, J, et al.Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:9961011.Google Scholar
2.Centers for Disease Control and Prevention. S. aureus and MRSA surveillance summary 2007. Available at: http://www.cdc.gov/ncidod/dhqp/ar_mrsa_surveillanceFS.html. Accessed September 30, 2008.Google Scholar
3.Garner, JS, Simmons, BP. Guideline for isolation precautions in hospitals. Infect Control 1983;4(Suppl 4):245325.Google ScholarPubMed
4.Garner, JS. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:5380.Google Scholar
5.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L; the Healthcare Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings, June 2007. Available at: http://www.cdc.gov/ncidod/dhqp/gl_isolation.html. Accessed September 30, 2008.Google Scholar
6.Institute for Healthcare Improvement. 100,000 Lives Campaign. Available at: http://www.ihi.org/IHI/programs/campaign/. Accessed February 15, 2009.Google Scholar
7.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L; the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-re-sistant organisms in healthcare settings, 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed April 14, 2008.Google Scholar
8.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24:362386.CrossRefGoogle ScholarPubMed
9.Calfee, DP, Salgado, CD, Classen, D, et al.Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(Suppl 1):S62S80.CrossRefGoogle ScholarPubMed
10.McGingle, KL, Gourlay, ML, Buchanan, IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 2008;46:17171728.Google Scholar